Corcept Therapeutics | CORT - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Alaunos Therapeutics USD 952K 60K 2026-06
ANI Pharmaceuticals USD 637.11M 39.9M 2026-09
Ardelyx USD 133.3M 6.04M 2026-06
Aurora Cannabis CAD 76.28M 28.24M 2026-06
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Canopy Growth CAD 98.74M 23K 2026-06
Corcept Therapeutics USD 225.75M 10.9M 2026-09
Eli Lilly USD 10.52B 496M 2026-06
J&J USD 18.93B 1.09B 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Merck USD 10.75B 5.02B 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novartis USD 9.88B 325M 2026-09
Novartis USD 13.19B 3.9B 2026-09
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 1.18B 995.96M 2026-09
Pfizer USD 89B 3.81B 2026-09
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
TG Therapeutics USD 218.66M 48.54M 2026-06